Premium
VENETOCLAX ( VEN ) IN PATIENTS WITH RELAPSED/REFRACTORY NON‐ H ODGKIN LYMPHOMA ( NHL )
Author(s) -
Davids M.S.,
Roberts A.W.,
Seymour J.F.,
Wierda W.G.,
Puvvada S.D.,
Gressick L.,
Alter D.,
Dunbar M.,
Zhou L.,
Kim S.,
Verdugo M.,
Gerecitano J.F.
Publication year - 2017
Publication title -
hematological oncology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.918
H-Index - 44
eISSN - 1099-1069
pISSN - 0278-0232
DOI - 10.1002/hon.2438_67
Subject(s) - medicine , neutropenia , gastroenterology , nausea , lymphoma , adverse effect , mantle cell lymphoma , marginal zone b cell lymphoma , ven , febrile neutropenia , toxicity , immunology , b cell , marginal zone , computer security , computer science , antibody